Kura Oncology, Inc.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) On April 9, 2026, our Board of Directors (the “Board”), upon the recommendation of the Compensation Committee of the Board, amended the Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”) and the 2015 Employee Stock Purchase Plan (the “ESPP”), in each case subject to stockholder approval, to, among other things, increase the number of shares of our common stock authorized for issuance under the 2014 Plan by 6,500,000 shares (the “Amended 2014 Plan”) and increase the number of shares of our common stock authorized for issuance under the ESPP by 2,500,000 shares (the “Amended ESPP”), respectively. On June 4, 2026, our stockholders approved the Amended 2014 Plan and the Amended ESPP. Complete copies of the Amended 2014 Plan and the Amended ESPP are filed herewith as Exhibit 99.1 and 99.2, respectively. The above summaries of the Amended 2014 Plan and Amended ESPP do not purport to be complete and are qualified in their entirety by reference to such exhibits.

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 4, 2026, we held our Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 6, 2026, the record date for the Annual Meeting, there were 88,762,704 shares of common stock outstanding, of which 69,778,580 shares of common stock were present virtually or represented by proxy at the Annual Meeting. At the Annual Meeting, stockholders: (1) elected Diane Parks, Mary T. Szela and Michael J. Vasconcelles, M.D. as Class III directors to hold office until our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal; (2) ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; (3) approved, on an advisory basis, the compensation paid to our named executive officers (“Say-on-Pay”) as disclosed in the proxy statement; (4) indicated, on an advisory basis, the preferred frequency of holding future Say-on-Pay advisory votes on executive compensation; (5) approved our Amended 2014 Plan; and (6) approved our Amended ESPP. The following sets forth detailed information regarding the final results of the voting for the Annual Meeting (with any fractional share amounts rounded to the nearest whole number): Proposal 1. Election of Directors Name of Director Elected For Withheld Broker Non-Votes ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Diane Parks 44,060,724 14,620,308 11,097,548 Mary T. Szela 38,859,502 19,821,530 11,097,548 Michael J. Vasconcelles, M.D. 58,169,894 511,138 11,097,548 Proposal 2. Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes ────────────────────────────────────────────────────────────── 69,385,497 140,763 252,320 — Proposal 3. Advisory Vote on Executive Compensation For Against Abstain Broker Non-Votes ────────────────────────────────────────────────────────────────── 48,783,834 1,141,854 8,755,344 11,097,548 Proposal 4. Advisory Indication on Frequency of Stockholder Advisory Votes on Executive Compensation 1 Year 2 Years 3 Years Abstain Broker Non-Votes ─────────────────────────────────────────────────────────────────────────────── 48,362,762 54,055 1,586,672 8,677,543 11,097,548 Based on these results and consistent with our recommendation, our Board of Directors has determined that we will conduct future stockholder advisory votes on the compensation of our named executive officers every year. Proposal 5. Approval of our Amended 2014 Plan For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────────── 48,402,820 10,099,296 178,916 11,097,548 Proposal 6. Approval of our Amended ESPP For Against Abstain Broker Non-Votes ────────────────────────────────────────────────────────────── 58,306,174 213,434 161,424 11,097,548